Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis

OBJECTIVE: Anti–tumor necrosis factor (anti-TNF) therapies are highly effective in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but a significant number of patients exhibit only a partial or no therapeutic response. Inflammation alters local and systemic metabolism, and TNF plays a role...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kapoor, Sabrina R, Filer, Andrew, Fitzpatrick, Martin A, Fisher, Benjamin A, Taylor, Peter C, Buckley, Christopher D, McInnes, Iain B, Raza, Karim, Young, Stephen P
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2013
Assuntos:
Rheumatoid Arthritis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715109/
https://ncbi.nlm.nih.gov/pubmed/23460124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.37921
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares